6981. [Experimental study of LAK and activated NK cells affecting hematopoiesis in mice].
To study the relationship between LAK/activated NK cells and hematopoiesis as well as the effects of LAK/activated NK cells on hematopoietic reconstitution after syngeneic bone marrow transplantation(BMT) in mice.
6982. [Successful treatment of AML by HLA-compatible sibling umbilical cord blood stem cell transplantation--the first case report in China].
To apply umbilical cord blood stem cell transplantation (UCBSCT) to the treatment of hematological malignancies, and to observe the persistent hematopoietic reconstitution, graft-versus-host disease (GVHD) and transplantation-related complications.
6983. [Heparin enhances the stimulating effect of thrombopoietin on megakaryocytopoiesis].
To verify whether heparin could enhance the stimulating effect of Tpo on megakaryocytopoiesis.
6984. [Expression of c-kit receptor on the hemopoietic stem/precursor cells of aplastic anemia patients].
To explore the expression of c-kit receptor(CD117) on the hemopoietic stem/precursor cells of aplastic anemia patients and its role in the genesis of aplastic hematopoiesis failure.
6985. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
To investigate the quality of bone marrow stem cells from aplastic anemia patients and their in vitro responses to hemopoietic growth factors(HGF).
6986. [Inhibition of hematopoiesis by sera from patients with myelodysplastic syndromes].
To explore the inhibitory effect of sera from patients with myelodysplastic syndromes (MDS) on the growth of normal hematopoietic progenitor cells.
6987. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
To investigate the expression of membrane associated complement regulatory proteins (CRP)--CD55 and CD59 on the peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria (PNH), aplastic anemia(AA) and myelodysplastic syndrome (MDS) and its clinical implications.
6988. [Advances in the study of hematopoietic cell apoptosis in multiple myeloma].6989. [Are CD34- cells the more primary hematopoietic stem cells?].6990. [The cytologic ultrastructure and cytochemical features of human dendritic cells from peripheral blood].
To observe the cytomorphological, cellular ultrastructure and cytochemical features of the dendritic cell (DC) enriched populations in vitro.
6991. [Studies on hematopoietic reconstitution by ex vivo expanded human cord blood hematopoietic stem/progenitor cells in SCID mice].
To elucidate the effect of the combination of cytokines on ex vivo expansion and self-renewal potential of human umbilical cord blood hematopoietic stem/progenitor cells.
6992. [Analysis of immunophenotype of hematopoietic stem/progenitor cells in human umbilical cord blood with flow cytometry and its significance].
To study the difference of immunophenotype of hematopoietic stem/progenitor cells (HSPCs) between human umbilical cord blood(UCB) and bone marrow(BM).
6993. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation].
In order to determine the status of engraftment following allogeneic bone marrow transplantation (allo-BMT) and predict the outcome, short tandem repeats (STR) were analysed by fluorescence labeling polymerase chain reaction (PCR).
6994. [Membranous nephropathy after allogeneic peripheral blood hematopoietic stem cell transplantation--clinicopathologic manifestations of a rare chronic GVHD].
To investigate the clinicopathologic characteristics of renal chronic graft versus host disease (GVHD) after allogeneic peripheral blood hematopoietic transplantation(HSCT).
6995. [Establishment of cord blood stem cell bank and its clinical application].
To establish unrelated cord blood stem cell bank for providing potential grafts for stem cell transplantation in the treatment of some malignant and nonmalignant disorders.
6996. [A preliminary result of treatment of progressive multiple sclerosis with autologous peripheral blood stem cell transplantation in China].
To explore the clinical effect for treatment of progressive multiple sclerosis (PMS) by autologous peripheral blood stem cell transplantation (Auto-PBSCT).
6997. [Cytomegalovirus enteritis in recipients of allogeneic peripheral blood stem cell transplantation].
To report 6 cases of cytomeganlovirus (CMV) enteritis in allogeneic bone marrow transplantation (allo-BMT) or peripheral blood stem cell transplantation(PBSCT) recipients and the outcome after treatment.
6998. [Advances in the study of the effects of mesenchymal stem cells on osteogenesis].6999. [Regulation of gene co-expression after bicistronic retrovirus-mediated gene transfer into human cord blood CD34+ cells].
To compare internal SV40 early promoter with IRES of the in regulatory effect on gene co-expression after retrovirus-mediated gene transfer into human cord blood CD34+ cells.
7000. [Establishment of banks of hematopoietic stem cells from umbilical blood]. |